---

Sugammadex — MD Anaesthesiology Exam Notes

---

1. Introduction

• "Sugar" → cyclodextrin (sugar ring)
• "Gammadex" → γ-cyclodextrin backbone

---

2. Chemistry & Physical Structure

• Consists of 8 glucose units arranged in a ring (cyclic oligosaccharide)
• Three-dimensional structure resembling a hollow truncated cone (doughnut)
• Hydrophobic cavity (interior) — traps the lipophilic steroidal NMBD
• Hydrophilic exterior — polar hydroxyl groups make the complex water-soluble
• Molecular weight: 2002 g/mol (sugammadex alone)
  • Sugammadex–rocuronium complex: 2532 g/mol
  • Sugammadex–vecuronium complex: 2640 g/mol

---

3. Mechanism of Action

1. Sugammadex encapsulates aminosteroid NMBDs (rocuronium > vecuronium >> pancuronium) in a 1:1 molar ratio via:
   • Hydrophobic interactions
   • Van der Waals forces
   • Hydrogen bonding
2. The tight binding creates a concentration gradient: free drug is removed from plasma → rocuronium/vecuronium diffuses away from the neuromuscular junction (NMJ) back into plasma → NMJ receptors are freed → NMB reverses
3. Association:dissociation rate for rocuronium–sugammadex = 25,000,000:1 (extremely tight, essentially irreversible)
4. Affinity for vecuronium is 2.5× lower than rocuronium (but still clinically effective)
5. Also binds the active metabolite of vecuronium (3-desacetylvecuronium)
6. No action on cholinesterase, nicotinic, or muscarinic receptors → no need for anticholinergic (atropine/glycopyrrolate) co-administration
7. Does NOT reverse benzylisoquinolinium NMBDs (cisatracurium, atracurium, mivacurium)

---

4. Pharmacokinetics

---

5. Dosing

• Reversal at 2 mg/kg: TOF ratio ≥ 0.9 achieved in 2–4 minutes
• Reversal is dose-dependent and faster than neostigmine at all depths
• Objective neuromuscular monitoring is mandatory to confirm adequate reversal before extubation

---

6. Clinical Advantages Over Neostigmine

---

7. Special Clinical Scenarios

Rapid Sequence Intubation (RSI) — "Cannot Intubate, Cannot Oxygenate"

• Rocuronium 1.2 mg/kg can replace succinylcholine for RSI
• If intubation fails: 16 mg/kg sugammadex IV reverses profound block within ~3 minutes
• This gives rocuronium a viable role in patients with succinylcholine contraindications (hyperkalemia, malignant hyperthermia risk, myopathies)

Re-intubation After Sugammadex

• After reversal with sugammadex, steroidal NMBDs (rocuronium, vecuronium) cannot be used for at least 24 hours (sugammadex still occupies binding sites)
• Benzylisoquinolinium NMBDs (cisatracurium) can be used as alternatives
• If re-dosing rocuronium within 24 h is unavoidable, expect prolonged onset and unpredictable block — use higher doses under monitoring

---

8. Special Populations

Pediatric Patients

• Sugammadex 2 mg/kg is effective for reversal of moderate NMB in children; 4 mg/kg for deep block
• Recovery in children is generally faster than in older adults

Elderly Patients

• Reversal may be slower (some patients ≥75 years take up to 9.9 minutes to reach TOF ratio ≥0.9)
• Highlights importance of quantitative monitoring before extubation in the elderly

Renal Impairment

• Sugammadex is contraindicated (not recommended) in severe renal failure (creatinine clearance <30 mL/min)
• The sugammadex–rocuronium complex accumulates — long-term exposure effects are unclear
• High-flux hemodialysis can remove the complex; low-flux hemodialysis is ineffective

Cardiac Disease

• Does not prolong QTc interval — safe in cardiac patients
• No significant hemodynamic side effects

Pregnancy / Obstetrics

• Uteroplacental transfer is minimal (<2–6%)
• No negative effects on embryonic, fetal, or postnatal development reported (animal data)
• Human data are limited; use with caution

---

9. Adverse Effects & Drug Interactions

Adverse Effects

Drug Interactions

---

10. Contraindications

• Severe renal failure (CrCl <30 mL/min)
• Known hypersensitivity to sugammadex
• Caution with use of hormonal contraceptives (counselling required)

---

11. Neostigmine vs. Sugammadex — Key Exam Comparison

---

12. High-Yield Points for MD Exam

1. Sugammadex = modified γ-cyclodextrin, works by encapsulation (not cholinesterase inhibition)
2. Binds rocuronium > vecuronium >> pancuronium; no action on benzylisoquinoliniums
3. 1:1 molar complex, association:dissociation = 25 million:1
4. Dosing: 2 mg/kg (moderate), 4 mg/kg (deep), 16 mg/kg (profound/RSI rescue)
5. No need for anticholinergic co-administration
6. After sugammadex: avoid steroidal NMBDs for 24 hours (use cisatracurium instead)
7. Contraindicated in severe renal failure (CrCl <30 mL/min)
8. Impairs hormonal contraceptives — advise alternative contraception for 7 days
9. Anaphylaxis within 4 minutes — treat with high-dose epinephrine
10. Can artificially prolong aPTT — not a true coagulopathy

---